Aranesp Related Clinical Trials
A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy [Terminated]
Safety and Efficacy Study of BCD-066 Compared to Aranesp� for Anemia Treatment in Chronic Kidney Disease Patients [Not yet recruiting]
Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers [Completed]
A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer [Active, not recruiting]
Darbepoetin Alfa in Anemic Low or Intermediate-1 Risk MDS Subjects [Active, not recruiting]
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease [Terminated]
Aranesp® Monthly Preference Study - 2 [Completed]
Study of Aranesp to Treat Anemia in Prostate Cancer Patients. [Completed]
A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen) [Recruiting]
Darbepoetin Alfa and Anemia of Cancer [Terminated]
An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD) [Completed]
Study to Evaluate Effectiveness of Aranesp® [Completed]
A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients [Not yet recruiting]
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT) [Completed]
Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease [Not yet recruiting]
Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia [Completed]
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy [Completed]
A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) [Completed]
Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia [Completed]
A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp� [Completed]
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer [Completed]
Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies [Completed]
Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis [Completed]
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide [Completed]
Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa [Completed]
Study of Transplant Related Anemia Treated With Aranesp® (STRATA) [Completed]
Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis [Completed]
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation [Completed]
Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury [Completed]
Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS) [Terminated]
A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia [Completed]
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Completed]
Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease [Completed]
A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor [Completed]
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced [Terminated]
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa [Completed]
R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma [Active, not recruiting]
Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects [Completed]
Darbepoetin Alfa MDS Companion Protocol [Recruiting]
Phase 2 Study of Darbepoetin Alfa Extended Dosing [Completed]
Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients. [Terminated]
ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer [Completed]
A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients [Completed]
The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial [Completed]
Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes [Not yet recruiting]
Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy [Completed]
FG-4592 in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa [Recruiting]
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. [Completed]
Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease [Completed]
TRANSFORM - Observational Cohort Study of Darbepoetin Alfa Use in European Union (EU) Hemodialysis Patients Switched From PEG Epoetin Beta [Completed]
Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) [Completed]
Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease [Completed]
Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis [Completed]
A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects [Completed]
Chemotherapy Related Anemia [Completed]
European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa [Completed]
Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus [Terminated]
STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients [Terminated]
PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease [Active, not recruiting]
Comparison Among Erythropoietin Stimulating Agents [Completed]
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer [Active, not recruiting]
Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis [Completed]
Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT) [Completed]
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer [Completed]
Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy [Completed]
Anemia in Patients With a Non-Myeloid Malignancy [Completed]
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Completed]
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy [Completed]
Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer [Completed]
Study of South African Dialysis Patients [Terminated]
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia [Completed]
Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy [Completed]
A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy [Terminated]
Study of Haemodialysis Patients Switching From Aranesp to Biosimilar [Completed]
Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD) [Recruiting]
Darbepoetin Administration to Preterm Infants [Active, not recruiting]
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia [Recruiting]
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia. [Completed]
Fixed Dose NESP Study in Subjects With CRI [Completed]
Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy [Completed]
AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies [Completed]
Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia [Completed]
Intracoronary Darbepoetin-alpha to Reduce The Infarct Size and Post-Infarct Remodeling [Completed]
A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome [Completed]
Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure [Completed]
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome [Completed]
Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) [Completed]
Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis [Completed]
Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia [Completed]
|